I linfomi non Hodgkin-HIV sistemici nell'era dell'HAART. Storia naturale

Translated title of the contribution: HIV-related NHL in the HAART era. Natural history

Senka Juzbasic, Michele Spina, Emanuela Vaccher, Umberto Tirelli

Research output: Contribution to journalArticle

Abstract

In the era of highly active antiretroviral therapy (HAART), systemic non-Hodgkin lymphoma (NHL) represented the most frequent cancer associated to HIV infection. In contrast to Kaposi's sarcoma and primary central nervous system lymphoma (PCNSL) wich incidence have been declining after introduction of HAART, systemic NHL-HIV has relatively stable remaind. Systemic HIV related NHL are markedly heterogeneous both histologically and clinically and this clinicophatological heterogenity reflects variability in the molecular lesions associated to these lymphomas and immunological status of these patients. The introduction of HAART has substantially modified the approach to HIV related lymphomas. The results of recent monoinstitutional study of Aviano Cancer's Institute on 235 patients have suggested that HAART would otherwise allow a long life expectancy with longer disease free survival and overall survival. In fact the reduced of morbidity of AIDS patients bought by HAART justified the use of aggressive antineoplastic therapies.

Original languageItalian
Pages (from-to)676-689
Number of pages14
JournalRecenti Progressi in Medicina
Volume92
Issue number11
Publication statusPublished - Nov 2001

Fingerprint

AIDS-Related Lymphoma
Highly Active Antiretroviral Therapy
Natural History
Non-Hodgkin's Lymphoma
Lymphoma
Kaposi's Sarcoma
Life Expectancy
Antineoplastic Agents
Disease-Free Survival
HIV Infections
Neoplasms
Acquired Immunodeficiency Syndrome
Central Nervous System
HIV
Morbidity
Survival
Incidence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

I linfomi non Hodgkin-HIV sistemici nell'era dell'HAART. Storia naturale. / Juzbasic, Senka; Spina, Michele; Vaccher, Emanuela; Tirelli, Umberto.

In: Recenti Progressi in Medicina, Vol. 92, No. 11, 11.2001, p. 676-689.

Research output: Contribution to journalArticle

@article{cb6bb38287674d668274095c3f805e9e,
title = "I linfomi non Hodgkin-HIV sistemici nell'era dell'HAART. Storia naturale",
abstract = "In the era of highly active antiretroviral therapy (HAART), systemic non-Hodgkin lymphoma (NHL) represented the most frequent cancer associated to HIV infection. In contrast to Kaposi's sarcoma and primary central nervous system lymphoma (PCNSL) wich incidence have been declining after introduction of HAART, systemic NHL-HIV has relatively stable remaind. Systemic HIV related NHL are markedly heterogeneous both histologically and clinically and this clinicophatological heterogenity reflects variability in the molecular lesions associated to these lymphomas and immunological status of these patients. The introduction of HAART has substantially modified the approach to HIV related lymphomas. The results of recent monoinstitutional study of Aviano Cancer's Institute on 235 patients have suggested that HAART would otherwise allow a long life expectancy with longer disease free survival and overall survival. In fact the reduced of morbidity of AIDS patients bought by HAART justified the use of aggressive antineoplastic therapies.",
keywords = "AIDS, Highly active antiretroviral therapy, HIV infection, Kaposi's sarcoma, Systemic non-Hodgkin lymphoma",
author = "Senka Juzbasic and Michele Spina and Emanuela Vaccher and Umberto Tirelli",
year = "2001",
month = "11",
language = "Italian",
volume = "92",
pages = "676--689",
journal = "Recenti Progressi in Medicina",
issn = "0034-1193",
publisher = "Il Pensiero Scientifico Editore s.r.l.",
number = "11",

}

TY - JOUR

T1 - I linfomi non Hodgkin-HIV sistemici nell'era dell'HAART. Storia naturale

AU - Juzbasic, Senka

AU - Spina, Michele

AU - Vaccher, Emanuela

AU - Tirelli, Umberto

PY - 2001/11

Y1 - 2001/11

N2 - In the era of highly active antiretroviral therapy (HAART), systemic non-Hodgkin lymphoma (NHL) represented the most frequent cancer associated to HIV infection. In contrast to Kaposi's sarcoma and primary central nervous system lymphoma (PCNSL) wich incidence have been declining after introduction of HAART, systemic NHL-HIV has relatively stable remaind. Systemic HIV related NHL are markedly heterogeneous both histologically and clinically and this clinicophatological heterogenity reflects variability in the molecular lesions associated to these lymphomas and immunological status of these patients. The introduction of HAART has substantially modified the approach to HIV related lymphomas. The results of recent monoinstitutional study of Aviano Cancer's Institute on 235 patients have suggested that HAART would otherwise allow a long life expectancy with longer disease free survival and overall survival. In fact the reduced of morbidity of AIDS patients bought by HAART justified the use of aggressive antineoplastic therapies.

AB - In the era of highly active antiretroviral therapy (HAART), systemic non-Hodgkin lymphoma (NHL) represented the most frequent cancer associated to HIV infection. In contrast to Kaposi's sarcoma and primary central nervous system lymphoma (PCNSL) wich incidence have been declining after introduction of HAART, systemic NHL-HIV has relatively stable remaind. Systemic HIV related NHL are markedly heterogeneous both histologically and clinically and this clinicophatological heterogenity reflects variability in the molecular lesions associated to these lymphomas and immunological status of these patients. The introduction of HAART has substantially modified the approach to HIV related lymphomas. The results of recent monoinstitutional study of Aviano Cancer's Institute on 235 patients have suggested that HAART would otherwise allow a long life expectancy with longer disease free survival and overall survival. In fact the reduced of morbidity of AIDS patients bought by HAART justified the use of aggressive antineoplastic therapies.

KW - AIDS

KW - Highly active antiretroviral therapy

KW - HIV infection

KW - Kaposi's sarcoma

KW - Systemic non-Hodgkin lymphoma

UR - http://www.scopus.com/inward/record.url?scp=0035210171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035210171&partnerID=8YFLogxK

M3 - Articolo

C2 - 11765662

AN - SCOPUS:0035210171

VL - 92

SP - 676

EP - 689

JO - Recenti Progressi in Medicina

JF - Recenti Progressi in Medicina

SN - 0034-1193

IS - 11

ER -